Chugai Pharmaceutical Co. Ltd. - Total Other Income Expense Net

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.

The item "Total-Other-Income-Expense-Net" stands at -28.00 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value at least since 03/31/2012, the period currently displayed.

Chugai Pharmaceutical Co. Ltd.'s third quarter result of -23.08 Billion JPY for the item "Total Other Income Expense Net" represents a decrease of -441.54 percent compared to it's second quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s third quarter result of -23.08 Billion JPY for the item "Total Other Income Expense Net" represents a decrease of -1,165.08 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s third quarter result of -28.00 Billion JPY for the item "Total Other Income Expense Net" represents a decrease of -314.97 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -31.95 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -31.95 Billion Japanese Yens.
The 3 year change is -105.12 Billion Japanese Yens.
The 5 year change is -21.75 Billion Japanese Yens.
The 10 year change is -28.35 Billion Japanese Yens.

The Serie's long term average value is 2.04 Billion Japanese Yens. It's latest available value, on 09/30/2025, is -30.03 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is -108.72 Billion.